Patent details

EP1100829 Title: USE OF BASILIXIMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS OR SKIN DISEASES

Basic Information

Publication number:
EP1100829
PCT Application Number:
PCT/EP/1999/005316
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP999442940
PCT Publication Number:
WO/2000/006604
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF BASILIXIMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS OR SKIN DISEASES
French Title of Invention:
BASILIXIMAB UTILISE POUR TRAITER LA POLYARTHRITE RHUMATOIDE OU LES MALADIES CUTANEES
German Title of Invention:
VERWENDUNG VON BASILIXIMAB ZUR BEHANDLUNG VON RHEUMATOIDER ARTHRITIS UND HAUTERKRANKUNGEN
SPC Number:

Dates

Filing date:
26/07/1999
Grant date:
05/09/2007
EP Publication Date:
05/09/2007
PCT Publication Date:
10/02/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/05/2001
EP B1 Publication Date:
05/09/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
26/07/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/07/1999
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
Novartis Pharma GmbH
Address:
Brunner Strasse 59, 1230 Wien, Austria (AT)

Name:
UNIVERSITY COLLEGE LONDON
Address:
Rowland Hill Street, London NW3 2PF, United Kingdom (GB)

Inventor

1

Name:
SCHREIER Max, H.
Address:
Switzerland (CH)

2

Name:
AMLOT Peter, Lloyd
Address:
United Kingdom (GB)

Priority

1

Priority Number:
9816281
Priority Date:
27/07/1998
Priority Country:
United Kingdom (GB)

2

Priority Number:
9912460
Priority Date:
27/05/1999
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07K 16/28;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
09/07/2018
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages